Interim Results from a Clinical Trial of Stem Cell Transplantation for Relapsing-Remitting MS

January 23, 2015 /
MS Research Study and Reports

Interim Results from a Clinical Trial of Stem Cell Transplan

Interim Results from a Clinical Trial of Stem Cell
Transplantation for Relapsing-Remitting MS

Results from the
first three years of a five-year study of stem cell transplantation
combined with high-dose immunotherapy show that more than 78% of people
with relapsing-remitting MS had no new disease activity. The final results
should help determine whether this will be a safe and effective solution
for people with MS.
Find Out More
~~~~~~~~~~~~~~~~~~~~
 Keep CURRENT with MS Views and News – OPT-IN here

.
.

Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews

Stay informed with MS news and information - Sign-up here

For MS patients, caregivers or clinicians, Care to chat about MS? Join Our online COMMUNITY


Share:

Categories

Latest Blog Posts